Platelet production bolstered with romiplostim approval.
Morrow
Thomas
T
Genentech Inc, USA.
D000208:Acute Disease; D001792:Blood Platelets / Q000187:drug effects; D002352:Carrier Proteins / Q000008:administration & dosage / Q000627:therapeutic use*; D002908:Chronic Disease; D017277:Drug Approval; D006801:Humans; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy* / Q000503:physiopathology; D011961:Receptors, Fc / Q000008:administration & dosage / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage / Q000627:therapeutic use*; D034061:Thrombopoiesis / Q000187:drug effects*; D013926:Thrombopoietin
D002352:Carrier Proteins; D011961:Receptors, Fc; D011993:Recombinant Fusion Proteins; D013926:Thrombopoietin; C488777:romiplostim